Filing Analysis

📝 Material Agreement Filed Jul 06, 2026
🟠 HIGH

Public Co Management Corp (PCMC) has entered into a Share Exchange Agreement to acquire Physicians Capital Management Corporation, which will result in a change of control. The transaction involves the issuance of significant amounts of common and preferred stock to Conrad Ivie, MD, who will gain approximately 80% ownership and control of the company.

🚩 Red Flags

  • Significant dilution: The exchange shares constitute ~80% of the fully diluted equity on an as-converted basis.
  • Control concentration: A single individual (Conrad Ivie, MD) will control the majority of the Board and 80% of the equity.
  • Convertible Preferred Stock: Large amounts of Series B preferred stock are subject to significant conversion ratios (4:1 and 8:1), which may lead to future massive dilution.
  • Shell company transition: The company is currently a shell, meaning it lacks active operations until this merger closes.

📋 Key Facts

  • PCMC to acquire all issued and outstanding shares of Physicians Capital Management Corporation from Conrad Ivie, MD.
  • Consideration consists of 68,566,368 shares of PCMC Common Stock and 24,913,918 shares of Preferred Stock (Series A, B-1, and B-2).
  • Conrad Ivie, MD will own approximately 80% of the company on an as-converted, fully-diluted basis post-closing.
  • The transaction includes a change in control: Ivie will appoint a majority of the Board and serve as CEO.
  • Series B-1 and B-2 Preferred Stock have conversion ratios of 4:1 and 8:1 respectively, with holding periods of 18 and 24 months.
  • The transaction is expected to close in Q3 2026.
  • PCMC will cease being a 'shell company' upon closing, triggering a requirement for a 'Super 8-K' filing.
📝 Material Agreement Filed Jul 03, 2025
🟡 MEDIUM

Public Co Management Corp has entered preliminary and substantive discussions regarding a potential business combination with the controlling shareholder of Physicians Capital Management Corporation, a healthcare facility developer/lessor. The company notes these discussions are exploratory and no definitive agreement has been reached.

🚩 Red Flags

  • Speculative nature: The discussions are described as 'exploratory' and there is no assurance a transaction will be completed.
  • Lack of definitive terms: No valuation, structure, or consideration has been disclosed.

📋 Key Facts

  • Entered preliminary and substantive discussions for a potential business combination.
  • Target entity: Controlling shareholder of Physicians Capital Management Corporation (Maryland Corp).
  • Physicians Capital Management Corporation specializes in acquiring/developing healthcare facilities and leasing them under long-term net leases.
  • No definitive agreement has been reached as of the filing date (July 3, 2025).
  • The company intends to file a Letter of Intent (LOI) if negotiations progress.
📝 Material Agreement Filed Aug 19, 2024
🟡 MEDIUM

Public Co Management Corp entered into a non-binding letter of intent to acquire DACTA SG Pte. Ltd., a Singapore-based cybersecurity and AI firm, via a business combination involving a change of control. Additionally, the company issued a modified SAFE to an investor for $100,000.

🚩 Red Flags

  • The business combination involves a 'change of control,' which often results in significant dilution or restructuring for existing shareholders.
  • The SAFE contains a finder's fee warrant (10%), which can be dilutive and is sometimes viewed as an unconventional compensation structure.

📋 Key Facts

  • Entered into a non-binding letter of intent (LOI) with DACTA SG Pte. Ltd. on August 16, 2024.
  • The LOI contemplates a business combination with Dacta stakeholders involving a change of control.
  • Dacta specializes in cybersecurity, digital transformation, and artificial intelligence.
  • Issued a modified Simple Agreement for Future Equity (SAFE) to Chad Crowley for $100,000.
  • The SAFE includes a 4% valuation interest and triggers upon an equity financing of at least $5,000,000 before June 30, 2025.
  • A finder's fee is established via a warrant for 10% of the preferred/common stock issued to the party that introduced the investor.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for PCMC

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial